Click Here to Download the Ofloxacin Med Guide

Growth through Global Partnerships

Product Development / Co-Development Model

Nivagen's business model is to identify and utilize the world`s best and economical CROs and CRAMs to develop and manufacture niche generic and OTC products.

Acquisition and Licensing Model

The US generic market is large and growing. The market is complex and fragmented and requires a variety of infrastructures to reach all major channels and segments.


Every business has its individual core strengths. One of Nivagen’s core strengths is the ability of our sales team to launch new generic products in the US market.

Welcome to Nivagen Pharmaceuticals

Nivagen is engaged in the development, acquisition and sales of generic prescription drugs and over the counter products for the North American market. Our vision is to deliver high quality products at affordable prices by leveraging global partnerships with the best FDA approved manufacturing facilities across the world.

Our sales and marketing personnel are among the best in the world. The US generic prescription market is currently at approximately $60 billion, and over $120 billion's worth of products will be coming off of patent protection in next 10 years. Nivagen believes that, with its strategic partnership model of global alliances with highly efficient pharmaceutical companies across the globe, we can provide cost savings to the consumer while creating value for all members of the supply chain.

Nivagen is focused in three areas of product development: development/co-development, acquisition/in-licensing, and providing sales and marketing services. We are actively looking to partner with CRO and CRAM to co-develop products. We are also acquiring existing products. If you are small FDA qualified manufacturer and want to launch your company or product in the US, Nivagen can provide complete turnkey solutions and cost effective delivery on an accelerated timeline.

Upcoming Events

Come Meet With Us

Nivagen will be at the following events in 2020:   ECRM Retail Pharmacy – Generic Rx EPPS – February 26-29, in New Orleans, Louisiana DCAT Week – March 23-26, in New York City, New York CPhI North America – May 2-5, Philadelphia, PA NACDS Total Store Expo 2020 – August 8-10, San Diego, CA CPhI Worldwide 2020 – October 13-15, in Milan, … Continued

Complete turnkey solutions and cost effective solutions delivered! Contact Us Now